Literature DB >> 11903228

Propionibacterium acnes and inflammation in acne; P. acnes has T-cell mitogenic activity.

U Jappe1, E Ingham, J Henwood, K T Holland.   

Abstract

BACKGROUND: Circumstantial evidence suggests that Propionibacterium acnes has a role in the inflammation of acne. This could be effected by antigenic or superantigenic or mitogenic reactions.
OBJECTIVES: The purpose of this investigation was to determine whether P. acnes had only antigenic activity or additional superantigenic and mitogenic activity.
METHODS: A lymphocyte transformation assay was used to detect responses to a mixture of eight P. acnes whole cell isolates, and their supernatant culture fluids. In order to determine the nature of T-cell reactions to P. acnes cells a mouse-antihuman major histocompatibility complex class II monoclonal antibody was used in the lymphocyte transformation assay to inhibit the antigenic stimulation of lymphocytes. An analysis of the T-cell receptor (TCR) variable region beta (BV) repertoire was undertaken using flow cytometry of the unstimulated and stimulated cells.
RESULTS: Peripheral blood mononuclear cells (PBMNC) from adults with no history of acne responded strongly to stationary growth phase cells of P. acnes, less strongly to cells in the exponential growth phase. No response was detected to supernatant culture fluids. PBMNC from five cord blood samples (CBMNC) responded maximally after 3 and 7 days of incubation with stationary growth phase cells of P. acnes. The reaction of CBMNC to P. acnes cells was not suppressed completely by the blocking antibody. The analysis of the TCRBV repertoire indicated that P. acnes induced no deletion or over-representation of certain BV element-bearing T cells. The TCRBV analysis was repeated after preincubation with the blocking antibody. Deletion of T cells bearing certain BV components occurred and there was no over-representation of T cells carrying certain BV components.
CONCLUSIONS: Two mechanisms of lymphocyte activation by P. acnes cells are proposed, antigen and mitogen driven. These results are consistent with the histological evidence of inflammation in acne lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11903228     DOI: 10.1046/j.1365-2133.2002.04602.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

Review 1.  [Pathophysiology of acne].

Authors:  C Borelli; G Plewig; K Degitz
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 2.  Skin microbiota: a source of disease or defence?

Authors:  A L Cogen; V Nizet; R L Gallo
Journal:  Br J Dermatol       Date:  2008-03       Impact factor: 9.302

3.  Expression, purification, crystallization and preliminary X-ray diffraction analysis of the soluble domain of PPA0092, a putative nitrite reductase from Propionibacterium acnes.

Authors:  Masaki Nojiri; Felicia Shirota; Daisuke Hira; Shinnichiro Suzuki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-01-07

Review 4.  Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum.

Authors:  Marco Ventura; Carlos Canchaya; Andreas Tauch; Govind Chandra; Gerald F Fitzgerald; Keith F Chater; Douwe van Sinderen
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

5.  Tretinoin: A Review of Its Anti-inflammatory Properties in the Treatment of Acne.

Authors:  Nicholas Schmidt; Eugene H Gans
Journal:  J Clin Aesthet Dermatol       Date:  2011-11

6.  [Acne. Current pathophysiologic considerations].

Authors:  K Degitz; F Ochsendorf
Journal:  Hautarzt       Date:  2008-06       Impact factor: 0.751

7.  Simultaneous testing of immunological sensitization to multiple antigens in sarcoidosis reveals an association with inorganic antigens specifically related to a fibrotic phenotype.

Authors:  E Beijer; R Kraaijvanger; C Roodenburg; J C Grutters; B Meek; M Veltkamp
Journal:  Clin Exp Immunol       Date:  2020-10-06       Impact factor: 4.330

Review 8.  Taurine bromamine (TauBr)--its role in immunity and new perspectives for clinical use.

Authors:  Janusz Marcinkiewicz
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

9.  Comparative genomics and transcriptomics of Propionibacterium acnes.

Authors:  Elzbieta Brzuszkiewicz; January Weiner; Antje Wollherr; Andrea Thürmer; Jennifer Hüpeden; Hans B Lomholt; Mogens Kilian; Gerhard Gottschalk; Rolf Daniel; Hans-Joachim Mollenkopf; Thomas F Meyer; Holger Brüggemann
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

10.  Proteomic identification of secreted proteins of Propionibacterium acnes.

Authors:  Carsten Holland; Tim N Mak; Ursula Zimny-Arndt; Monika Schmid; Thomas F Meyer; Peter R Jungblut; Holger Brüggemann
Journal:  BMC Microbiol       Date:  2010-08-27       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.